Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
Top Cited Papers
- 22 May 2021
- journal article
- review article
- Published by Taylor & Francis Ltd in Infectious Diseases
- Vol. 53 (10), 737-754
- https://doi.org/10.1080/23744235.2021.1924397
Abstract
Long COVID or post-COVID-19 syndrome first gained widespread recognition among social support groups and later in scientific and medical communities. This illness is poorly understood as it affects COVID-19 survivors at all levels of disease severity, even younger adults, children, and those not hospitalized. While the precise definition of long COVID may be lacking, the most common symptoms reported in many studies are fatigue and dyspnoea that last for months after acute COVID-19. Other persistent symptoms may include cognitive and mental impairments, chest and joint pains, palpitations, myalgia, smell and taste dysfunctions, cough, headache, and gastrointestinal and cardiac issues. Presently, there is limited literature discussing the possible pathophysiology, risk factors, and treatments in long COVID, which the current review aims to address. In brief, long COVID may be driven by long-term tissue damage (e.g. lung, brain, and heart) and pathological inflammation (e.g. from viral persistence, immune dysregulation, and autoimmunity). The associated risk factors may include female sex, more than five early symptoms, early dyspnoea, prior psychiatric disorders, and specific biomarkers (e.g. D-dimer, CRP, and lymphocyte count), although more research is required to substantiate such risk factors. While preliminary evidence suggests that personalized rehabilitation training may help certain long COVID cases, therapeutic drugs repurposed from other similar conditions, such as myalgic encephalomyelitis or chronic fatigue syndrome, postural orthostatic tachycardia syndrome, and mast cell activation syndrome, also hold potential. In sum, this review hopes to provide the current understanding of what is known about long COVID.Keywords
This publication has 198 references indexed in Scilit:
- Osteonecrosis of the femoral head in SARS patients: seven years laterEuropean Journal of Orthopaedic Surgery & Traumatology, 2012
- Validation of new biomarkers in systemic autoimmune diseasesNature Reviews Rheumatology, 2011
- Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic optionsJournal of Hematology & Oncology, 2011
- Mast cell activation syndrome: Proposed diagnostic criteriaJournal of Allergy and Clinical Immunology, 2010
- Delirium as a predictor of long-term cognitive impairment in survivors of critical illnessCritical Care Medicine, 2010
- The long‐term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health statusRespirology, 2010
- Mental Morbidities and Chronic Fatigue in Severe Acute Respiratory Syndrome SurvivorsArchives of Internal Medicine, 2009
- Nature and functions of autoantibodiesNature Clinical Practice Rheumatology, 2008
- Hyperadrenergic Postural Tachycardia Syndrome in Mast Cell Activation DisordersHypertension, 2005
- The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and StudyAnnals of Internal Medicine, 1994